[go: up one dir, main page]

TR199900326T2 - Üst solunum yollari alerjik tepkisinin histamin reseptör antagonistlerin bir birlesimi ile tedavisi. - Google Patents

Üst solunum yollari alerjik tepkisinin histamin reseptör antagonistlerin bir birlesimi ile tedavisi.

Info

Publication number
TR199900326T2
TR199900326T2 TR1999/00326T TR9900326T TR199900326T2 TR 199900326 T2 TR199900326 T2 TR 199900326T2 TR 1999/00326 T TR1999/00326 T TR 1999/00326T TR 9900326 T TR9900326 T TR 9900326T TR 199900326 T2 TR199900326 T2 TR 199900326T2
Authority
TR
Turkey
Prior art keywords
treatment
combination
receptor antagonists
upper respiratory
allergic response
Prior art date
Application number
TR1999/00326T
Other languages
English (en)
Inventor
Kreutner William
A. Hey John
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of TR199900326T2 publication Critical patent/TR199900326T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Rhinitis semptomlarinin yok edilmesi, (a) antihistaminik etkili bir miktarda bir histamin H1 reseptör antagonist ile beraber (b) bir burun dekonjestant etkisini saglamak için yeterli miktarda bir histamin H3 reseptör antagonistin uygulanmasiyla elde edilmektedir. Bilesimler, bilesimlerin ikisininde terapötik sistemik seviyesini ayni düzeyde tutmak amaciyla, toplu halde tek bir dozaj seklinde ya da ayri ayri, ayni ya da farkli dozaj sekillerinde verilebilir.
TR1999/00326T 1996-08-16 1997-08-13 Üst solunum yollari alerjik tepkisinin histamin reseptör antagonistlerin bir birlesimi ile tedavisi. TR199900326T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68995196A 1996-08-16 1996-08-16

Publications (1)

Publication Number Publication Date
TR199900326T2 true TR199900326T2 (tr) 1999-05-21

Family

ID=24770500

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00326T TR199900326T2 (tr) 1996-08-16 1997-08-13 Üst solunum yollari alerjik tepkisinin histamin reseptör antagonistlerin bir birlesimi ile tedavisi.

Country Status (25)

Country Link
EP (1) EP0920315B1 (tr)
JP (2) JP3638289B2 (tr)
KR (1) KR20000029975A (tr)
CN (1) CN1152682C (tr)
AR (1) AR008293A1 (tr)
AT (1) ATE314071T1 (tr)
AU (1) AU722040B2 (tr)
BR (1) BR9711149A (tr)
CA (1) CA2263163A1 (tr)
CO (1) CO4910138A1 (tr)
CZ (1) CZ43299A3 (tr)
DE (1) DE69734984D1 (tr)
HU (1) HUP9904362A3 (tr)
ID (1) ID17871A (tr)
IL (1) IL128573A0 (tr)
MY (1) MY116130A (tr)
NO (1) NO990706D0 (tr)
NZ (1) NZ334063A (tr)
PE (1) PE100298A1 (tr)
PL (1) PL191073B1 (tr)
SK (1) SK20099A3 (tr)
TR (1) TR199900326T2 (tr)
TW (2) TWI221768B (tr)
WO (1) WO1998006394A1 (tr)
ZA (1) ZA977263B (tr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527201A (en) * 1997-03-26 2004-12-24 Sepracor Inc Stable norastemizole formulations comprising coated norastemizole particles
ID22891A (id) * 1997-08-26 1999-12-16 Hoechst Marion Roussel Inc Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
CN1285828A (zh) * 1997-11-07 2001-02-28 先灵公司 被含有一个氮原子的五、六或七元杂环取代的咪唑基烷基
JP2001522836A (ja) * 1997-11-07 2001-11-20 シェーリング コーポレイション Ｈ３レセプターアンタゴニストとしてのフェニル−アルキル−イミダゾール
CA2308586A1 (en) * 1997-11-07 1999-05-20 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
AU6252699A (en) * 1998-10-09 2000-05-01 Schering Corporation Composition and method for treating allergic diseases
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
PE20010752A1 (es) * 1999-09-22 2001-07-17 Schering Corp Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios
HK1046367A1 (zh) * 2000-02-03 2003-01-10 Schering Corporation 治疗过敏和炎症症状
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
GB2373186A (en) * 2001-02-23 2002-09-18 Astrazeneca Ab Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
JP4522651B2 (ja) 2001-03-13 2010-08-11 シェーリング コーポレイション 新規非イミダゾール化合物
US7105505B2 (en) 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
CA2482551C (en) 2002-04-18 2009-08-11 Schering Corporation 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
AU2003243709B2 (en) 2002-06-24 2007-01-18 Schering Corporation Indole derivatives useful as histamine H3 antagonists
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
KR20080021082A (ko) 2005-06-20 2008-03-06 쉐링 코포레이션 히스타민 ｈ3 길항제로서 유용한 피페리딘 유도체
EP2318388A2 (en) 2008-07-23 2011-05-11 Schering Corporation Tricyclic spirocycle derivatives and methods of use thereof
EP2350048A2 (en) 2008-10-16 2011-08-03 Schering Corporation Azine derivatives and methods of use thereof
WO2010071822A1 (en) 2008-12-19 2010-06-24 Schering Corporation Piperidine and piperazine derivatives and methods of use thereof
US8283360B2 (en) 2008-12-19 2012-10-09 Merck Sharp & Dohme Corp. Bicyclic heterocyclic derivatives and methods of use thereof
PT2408453T (pt) 2009-03-17 2022-04-05 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
EP2429530B1 (en) * 2009-05-14 2018-11-07 The General Hospital Corporation (s)-meclizine for treating ischaemia-reperfusion injury
US8759357B2 (en) 2009-10-08 2014-06-24 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (FABP)
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
RU2685277C1 (ru) * 2018-05-24 2019-04-17 Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment

Also Published As

Publication number Publication date
EP0920315B1 (en) 2005-12-28
SK20099A3 (en) 2000-08-14
ZA977263B (en) 1998-02-16
HUP9904362A2 (hu) 2000-11-28
PE100298A1 (es) 1999-01-11
JP2003095979A (ja) 2003-04-03
HUP9904362A3 (en) 2000-12-28
TW200427450A (en) 2004-12-16
TWI221768B (en) 2004-10-11
DE69734984D1 (de) 2006-02-02
MY116130A (en) 2003-11-28
PL191073B1 (pl) 2006-03-31
NO990706L (no) 1999-02-15
AU722040B2 (en) 2000-07-20
AR008293A1 (es) 1999-12-29
NO990706D0 (no) 1999-02-15
EP0920315A1 (en) 1999-06-09
AU3973397A (en) 1998-03-06
CO4910138A1 (es) 2000-04-24
JP3638289B2 (ja) 2005-04-13
ID17871A (id) 1998-02-05
CZ43299A3 (cs) 1999-07-14
ATE314071T1 (de) 2006-01-15
CN1152682C (zh) 2004-06-09
KR20000029975A (ko) 2000-05-25
CN1233179A (zh) 1999-10-27
PL331617A1 (en) 1999-08-02
NZ334063A (en) 2000-09-29
IL128573A0 (en) 2000-01-31
WO1998006394A1 (en) 1998-02-19
BR9711149A (pt) 1999-08-17
CA2263163A1 (en) 1998-02-19
JP2000505094A (ja) 2000-04-25

Similar Documents

Publication Publication Date Title
TR199900326T2 (tr) Üst solunum yollari alerjik tepkisinin histamin reseptör antagonistlerin bir birlesimi ile tedavisi.
WO2002058620A3 (es) Composiciones farmaceuticas que contienen un inhibidor de cox-ii y un relajante muscular
NO20003277L (no) Opoid agonist/antagonist kombinasjoner
DE60231911D1 (de) Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen
HUT76644A (en) Substituted piperidines, pharmaceutical compositions containing them and their use
ATE326222T1 (de) Naloxon- und naltrexon-analoga in der behandlung bei drogenmissbrauch
CA2304162A1 (en) Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
NZ592039A (en) Combination therapy for the treatment of ocular neovascular disorders
WO2004017896A3 (en) Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist
ES2196898T3 (es) Antagonistas de receptores de crf y metodos relacionados.
DK1027053T3 (da) Fremgangsmåde til forebyggelse af nefrotoksicitet forårsaget af cyclosporiner eller tacrolimuser
NO996442L (no) Anvendelse av en spesifikk antagonist for 5HT2 reseptorer for fremstilling av medisiner som er anvendbare for behandling av søvnapnésyndromet
NO20051023L (no) Oral administrering av calcitonin
ATE289506T1 (de) Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
Njaa et al. Levocabastine compared with sodium cromoglygate eyedrops in children with both birch and grass pollen allergy
Glazier Potentiation of pain relief with hydroxyzine: a therapeutic myth?
DE69831416T2 (de) Chinolin-harnstoff-derivate zur behandlung von entzugssyndrom und durch entzugssyndrom verursachten gehirnschaden
WO1997001340A1 (en) The combination of topical nasal antihistamines and topical nasal mast cell stabilizers
DE69603615D1 (de) Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie
DK0942729T3 (da) Anvendelse af NK-1-receptorantagonister til behandling af stresslidelser
CA2405238A1 (en) Single-dose antihistamine/decongestant formulations for treating rhinitis
ECSP972225A (es) Tratamiento de las respuestas alergicas de las vias respiratorias superiores (caso al0642k)
Ratner et al. Tecastemizole produces rapid and sustained symptom reduction in seasonal allergic rhinitis
Cellini et al. Topical allergy induced by administration of timolol maleate.